Results for tag: "Familial Chylomicronemia Syndrome Drugs"

Familial Chylomicronemia Syndrome (FCS) is a rare genetic disorder that affects the metabolism of lipids, or fats, in the body. It is characterized by the accumulation of chylomicrons, which are large particles of fat, in the bloodstream. This can lead to a variety of symptoms, including abdominal pain, fatigue, and pancreatitis. Treatment for FCS typically involves lifestyle modifications, such as a low-fat diet, and medications to reduce the levels of fat in the blood. The market for drugs to treat FCS is relatively small, but growing. These drugs are typically used to reduce the levels of fat in the blood, as well as to reduce the risk of complications associated with the disorder. Examples of drugs used to treat FCS include fenofibrate, gemfibrozil, and omega-3 fatty acids. Companies in the FCS drugs market include Amgen, AstraZeneca, Merck, and Pfizer. Show Less Read more